Clinical Trial Update: A Study of TFX05-01 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for TFX05-01 in patients with advanced solid tumors, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• TFX05-01

Snippet

Sponsor: Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN